NVO240628P146000
- 3.26
- 0.000.00%
Novo-Nordisk A/S Newsroom
Biden and Sanders teamed up to pressure Novo Nordisk and Eli Lilly to lower the price of weight loss drugs.
① Biden pointed out that the prices of pharmaceutical products from Novo-Nordisk and Eli Lilly and Co are "unreasonably high" and far exceed those of other countries, which is unacceptable. ② If these pharmaceutical companies refuse to significantly reduce prescription drug prices in the United States and end their greedy behavior, we will do "everything we can to help them stop this behavior."
Research warns of new risks with "miracle weight-loss drugs": there may be a correlation with a certain eye disease.
① The study came from the Massachusetts Eye and Ear Hospital in the US, a hospital that specializes in treating eye, ear, nose, throat, and head and neck diseases, and is also a teaching hospital affiliated to Harvard Medical School; ② The results showed that taking simeglutide prescriptions poses a potential risk of developing NAION, but further research is needed to assess the causal relationship.
Unusual Options Activity: AAL, RIVN and Others Attract Market Bets, AAL V/OI Ratio Reaches 170.7
EST Jul 3rd Afternoon Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June's sharply lower-than-expected services sector activ
Sector Update: Health Care Stocks Fall in Afternoon Trading
Health care stocks declined Wednesday afternoon with the NYSE Health Care Index shedding 1% and the Health Care Select Sector SPDR Fund (XLV) retreating 0.8%. The iShares Biotechnology ETF (IBB) fell
Using Obesity Drugs? Potential Vision Loss Disorder Linked To Novo Nordisk's Ozempic And Wegovy, Study Finds
A new observational study has identified a potential link between Novo Nordisk A/S's (NYSE:NVO) GLP-1 drugs, Ozempic and Wegovy (semaglutide), and a serious eye condition known as nonarteritic anterio
Novo Nordisk's Weight Loss Drug Linked to Eye Disorder in Small Study
Top Midday Stories: Southwest Board Approves Shareholder Rights Plan; National Amusements Agrees to Preliminary Deal to Sell Paramount to Skydance; Ozempic, Wegovy Linked to Blinding Eye Condition, Study Says
The S&P 500 and the Nasdaq Composite were both up in late-morning trading Wednesday while the Dow Jones Industrial Average was down as investors prepare for another big jobs report Friday. In company
US stocks fluctuate | Shares related to weight loss drugs decline and Novo Nordisk (NVO.US) falls by more than 4%.
According to the Zhītōng Cáijīng APP, on Wednesday, stocks related to weight loss drugs fell. As of press time, Novo-Nordisk (NVO.US) fell more than 4%, Eli Lilly and Co (LLY.US) fell 1.6%, and Pfizer (PFE.US) fell 0.34%. Analysis by doctors at the Massachusetts Eye and Ear Hospital affiliated with Harvard University showed that Novo-Nordisk's popular weight loss drugs Ozempic and Wegovy appear to be associated with an increased risk of rare vision loss. Research on medical records shows that compared to those who use other weight loss drugs, those who use Novo-Nordisk's...
Novo Nordisk Shares See Further Drop; 'Study Links Ozempic To Higher Risk Of Eye Condition That Can Cause Vision Loss' - STAT News
A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk's GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss.After hearing
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.6% to 1,436.74 on the S&P Europe Select ADR Index. From continental Europe, the
Ozempic, Wegovy Linked to Higher Risk of Blinding Eye Condition, Study Says
11:23 AM EDT, 07/03/2024 (MT Newswires) -- Ozempic, Wegovy Linked to Higher Risk of Blinding Eye Condition, Study Says Price: 138.67, Change: -4.31, Percent Change: -3.01
Express News | Novo Nordisk ADR fell 3.8% to the lowest since June 4th.
'Potential Link Between Ozempic, Wegovy And Serious Eye Condition Revealed In New Study' - New York Post
Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss.The risk of developing nonarteritic anterior ischemic optic neurop
Tesla, Paramount, Nvidia, Constellation Brands, and More Stock Market Movers
Tesla stock extends gains after second-quarter deliveries at the electric-vehicle make beat expectations, while Paramount surges following a report it has reached a deal to merge with Skydance Media.
Update: US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices
Eli Lilly (LLY.SW) and Novo Nordisk (NOVO-B.CO) were singled out by US President Joe Biden for "price gouging" and "corporate greed" for the prices of their diabetes and obesity drugs in the country.
Futu Morning News | Technology stocks continue to soar! Tesla rose more than 10%, Apple and Amazon hit new highs together; Powell's latest statement: Significant progress in reducing inflation.
Biden will meet with Democratic governors to seek support, and several popular candidates for succession will attend. Tesla delivered 444,000 vehicles in the second quarter, higher than expected in the market. Apple is expected to gain a seat on the OpenAI board of directors as an observer.
US stocks close | S&P and Nasdaq hit new closing highs, Amazon, Apple, and Microsoft hit new highs again, and Tesla surged more than 10%.
Chinese concept stocks index rebounds and breaks away from its 5-month low, with alibaba, nio inc, li auto inc rising about 2%.
Fighting Words: Lilly and Novo Swat Back at the Biden/Sanders Call for Lower GLP-1 Prices
Update: Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say
(Updates with Novo Nordisk's comment starting in the third paragraph.) Novo Nordisk A/S (NVO) and Eli Lilly (LLY) are charging "unconscionably" high prices for their prescription drugs, President Joe